MediWound (MDWD) Other Non-Current Assets (2013 - 2025)
MediWound (MDWD) recorded quarterly Other Non-Current Assets of $439000.0 in Q4 2025, down 3.09% quarter-over-quarter from $453000.0 in Q2 2025, and little changed on a YoY basis from $439000.0 in Q4 2024.
MediWound (MDWD) Other Non-Current Assets (2013 - 2025) Analysis & Trends
MediWound's Other Non-Current Assets history runs 13 years deep, the most recent figure standing at $439000.0 for Q4 2025.
- In Q4 2025, Other Non-Current Assets changed 0.0% year-over-year to $439000.0; the TTM figure through Dec 2025 stood at $439000.0 (changed 0.0% YoY), while the FY2025 annual figure was $439000.0, changed 0.0% from the prior year.
- Other Non-Current Assets was $439000.0 for Q4 2025 at MediWound, down from $453000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $453000.0 in Q2 2024 to a low of $166000.0 in Q3 2022.
- Historically, Other Non-Current Assets has averaged $318866.7 across 5 years, with a median of $433000.0 in 2023.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets declined 9.29% in 2022, then surged 160.84% in 2023.
- A 5-year view of Other Non-Current Assets shows it stood at $183000.0 in 2021, then gained by 0.55% to $184000.0 in 2022, then soared by 139.13% to $440000.0 in 2023, then fell by 0.23% to $439000.0 in 2024, then changed by 0.0% to $439000.0 in 2025.
- The last three Other Non-Current Assets figures came in at $439000.0 (Q4 2025), $453000.0 (Q2 2025), and $439000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 | 439,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 439,000.00 |
| Jun 30, 2025 | 453,000.00 |
| Dec 31, 2024 | 439,000.00 |
| Sep 30, 2024 | 434,000.00 |
| Jun 30, 2024 | 453,000.00 |
| Mar 31, 2024 | 446,000.00 |
| Dec 31, 2023 | 440,000.00 |
| Sep 30, 2023 | 433,000.00 |
| Dec 31, 2022 | 184,000.00 |
| Sep 30, 2022 | 166,000.00 |
| Jun 30, 2022 | 168,000.00 |
| Mar 31, 2022 | 185,000.00 |
| Sep 30, 2021 | 183,000.00 |
| Jun 30, 2021 | 182,000.00 |
| Mar 31, 2021 | 178,000.00 |
| Dec 31, 2020 | 184,000.00 |
| Sep 30, 2020 | 181,000.00 |
| Jun 30, 2020 | 179,000.00 |
| Mar 31, 2020 | 174,000.00 |
| Dec 31, 2019 | 180,000.00 |